|
HY-100741C-1mg
|
MedChemexpress LLC
|
(R,R)-S63845
|
|
|
|
|
HY-100741C-10mg
|
MedChemexpress LLC
|
(R,R)-S63845
|
|
|
|
|
HY-100741C-100mg
|
MedChemexpress LLC
|
(R,R)-S63845
|
|
|
|
|
HY-100741C-25mg
|
MedChemexpress LLC
|
(R,R)-S63845
|
|
|
|
|
HY-100741C-5mg
|
MedChemexpress LLC
|
(R,R)-S63845
|
|
|
|
|
HY-100741C-50mg
|
MedChemexpress LLC
|
(R,R)-S63845
|
|
|
|
|
HY-100741A-1mg
|
MedChemexpress LLC
|
(S,R)-S63845
|
|
|
|
|
HY-100741A-10mg
|
MedChemexpress LLC
|
(S,R)-S63845
|
|
|
|
|
HY-100741A-100mg
|
MedChemexpress LLC
|
(S,R)-S63845
|
|
|
|
|
HY-100741A-25mg
|
MedChemexpress LLC
|
(S,R)-S63845
|
|
|
|
|
HY-100741A-5mg
|
MedChemexpress LLC
|
(S,R)-S63845
|
|
|
|
|
HY-100741A-50mg
|
MedChemexpress LLC
|
(S,R)-S63845
|
|
|
|
|
HY-111457-10mg
|
MedChemexpress LLC
|
BAY-677 [CAS 2117404-84-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111457-25mg
|
MedChemexpress LLC
|
BAY-677 [CAS 2117404-84-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111457-5mg
|
MedChemexpress LLC
|
BAY-677 [CAS 2117404-84-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111457-50mg
|
MedChemexpress LLC
|
BAY-677 [CAS 2117404-84-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-111457-1mL
|
MedChemexpress LLC
|
BAY-677 [CAS 2117404-84-7] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-153081-100ug
|
MedChemexpress LLC
|
eGFP circRNA
|
|
|
|
|
HY-153081-500ug
|
MedChemexpress LLC
|
eGFP circRNA
|
|
|
|
|
HY-151460-1mg
|
MedChemexpress LLC
|
GCN2-IN-7 [CAS 2396465-33-9]
|
|
Cancer-programmed cell death
|
|
|
HY-151460-10mg
|
MedChemexpress LLC
|
GCN2-IN-7 [CAS 2396465-33-9]
|
|
Cancer-programmed cell death
|
|
|
HY-151460-100mg
|
MedChemexpress LLC
|
GCN2-IN-7 [CAS 2396465-33-9]
|
|
Cancer-programmed cell death
|
|
|
HY-151460-25mg
|
MedChemexpress LLC
|
GCN2-IN-7 [CAS 2396465-33-9]
|
|
Cancer-programmed cell death
|
|
|
HY-151460-5mg
|
MedChemexpress LLC
|
GCN2-IN-7 [CAS 2396465-33-9]
|
|
Cancer-programmed cell death
|
|
|
HY-151460-50mg
|
MedChemexpress LLC
|
GCN2-IN-7 [CAS 2396465-33-9]
|
|
Cancer-programmed cell death
|
|
